Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABPM study of Tlando in hypogonadal men
NCT03868059Phase 3Completed
- Sponsor
- Lipocine Inc
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TSX-011 in male hypogonadism, sponsored by Lipocine Inc. Started Apr 2018; status: completed.
02
Drugs
TSX-011
03
Conditions
male hypogonadism
Beyond the preview
Go deeper on NCT03868059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03868059.